Arwen Stikvoort

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Journal article: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. 2023;149(8):4173-4184

Radiation modulates expression and related activities of c-Met protein in oral tongue squamous cell carcinoma cell lines.

Al-Jamaei AAH; de Visscher JGAM; Forouzanfar T; Brakenhoff RH; Leemans CR; Stikvoort A; Zandieh-Doulabi B; Helder MN
Article: HAEMATOLOGICA. 2022;107(8):1786-1795

A novel CD34-specific T-cell engager efficiently depletes acute myeloid leukemia and leukemic stem cells in vitro and in vivo.

Arruda LCM; Stikvoort A; Lambert M; Jin L; Rivera LS; Alves RMP; De Moura TR; Mim C; Lehmann S; Axelsson-Robertson R; Dick JE; Mattsson J; Önfelt B; Carlsten M; Uhlin M
Article: HAEMATOLOGICA. 2022;107(2):437-445

CD38 knockout natural killer cells expressing an affinity optimized CD38 chimeric antigen receptor successfully target acute myeloid leukemia with reduced effector cell fratricide.

Gurney M; Stikvoort A; Nolan E; Kirkham-McCarthy L; Khoruzhenko S; Shivakumar R; Zweegman S; Van de Donk NWCJ; Mutis T; Szegezdi E; Sarkar S; O'Dwyer M
Article: HEMASPHERE. 2021;5(7):e596

CD38-specific Chimeric Antigen Receptor Expressing Natural Killer KHYG-1 Cells: A Proof of Concept for an "Off the Shelf" Therapy for Multiple Myeloma.

Stikvoort A; van der Schans J; Sarkar S; Poels R; Ruiter R; Naik J; Yuan H; de Bruijn JD; van de Donk NWCJ; Zweegman S; Themeli M; Groen R; O'Dwyer M; Mutis T
Article: HEMASPHERE. 2021;5(5):e561

Bone Marrow Mesenchymal Stromal Cell-mediated Resistance in Multiple Myeloma Against NK Cells can be Overcome by Introduction of CD38-CAR or TRAIL-variant.

Holthof LC; Stikvoort A; van der Horst HJ; Gelderloos AT; Poels R; Li F; Groen RWJ; Zweegman S; van de Donk NWCJ; O'Dwyer M; Mutis T
Journal article: HEMASPHERE. 2021;5(7)

CD38-specific Chimeric Antigen Receptor Expressing Natural Killer KHYG-1 Cells: A Proof of Concept for an "Off the Shelf" Therapy for Multiple Myeloma

Stikvoort A; van der Schans J; Sarkar S; Poels R; Ruiter R; Naik J; Yuan H; de Bruijn JD; van de Donk NWCJ; Zweegman S; Themeli M; Groen R; O'Dwyer M; Mutis T
Journal article: HEMASPHERE. 2021;5(5)

Bone Marrow Mesenchymal Stromal Cell-mediated Resistance in Multiple Myeloma Against NK Cells can be Overcome by Introduction of CD38-CAR or TRAIL-variant

Holthof LC; Stikvoort A; van der Horst HJ; Gelderloos AT; Poels R; Li F; Groen RWJ; Zweegman S; van de Donk NWCJ; O'Dwyer M; Mutis T
Article: BONE MARROW TRANSPLANTATION. 2019;54(10):1562-1574

T-cell frequencies of CD8+ γδ and CD27+ γδ cells in the stem cell graft predict the outcome after allogeneic hematopoietic cell transplantation.

Gaballa A; Stikvoort A; Önfelt B; Mattsson J; Sundin M; Watz E; Uhlin M
Article: ONCOIMMUNOLOGY. 2019;8(2):e1535730

Immune profiling and identification of prognostic immune-related risk factors in human ovarian cancer.

Rådestad E; Klynning C; Stikvoort A; Mogensen O; Nava S; Magalhaes I; Uhlin M
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2018;24(3):467-477

Risk Factors for Severe Acute Graft-versus-Host Disease in Donor Graft Composition.

Stikvoort A; Gaballa A; Solders M; Nederlof I; Önfelt B; Sundberg B; Remberger M; Sundin M; Mattsson J; Uhlin M
Article: JOURNAL OF LEUKOCYTE BIOLOGY. 2017;101(3):623-632

Frontline Science: Placenta-derived decidual stromal cells alter IL-2R expression and signaling in alloantigen-activated T cells.

Erkers T; Solders M; Verleng L; Bergström C; Stikvoort A; Rane L; Nava S; Ringdén O; Kaipe H
Article: FRONTIERS IN IMMUNOLOGY. 2017;8:717

Combining Flow and Mass Cytometry in the Search for Biomarkers in Chronic Graft-versus-Host Disease.

Stikvoort A; Chen Y; Rådestad E; Törlén J; Lakshmikanth T; Björklund A; Mikes J; Achour A; Gertow J; Sundberg B; Remberger M; Sundin M; Mattsson J; Brodin P; Uhlin M
Article: PLOS ONE. 2016;11(5):e0154737

Long-Term Stable Mixed Chimerism after Hematopoietic Stem Cell Transplantation in Patients with Non-Malignant Disease, Shall We Be Tolerant?

Stikvoort A; Sundin M; Uzunel M; Gertow J; Sundberg B; Schaffer M; Mattsson J; Uhlin M
Article: JOURNAL OF IMMUNOLOGY RESEARCH. 2016;2016:5601204-11

Donor Cell Composition and Reactivity Predict Risk of Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.

Sairafi D; Stikvoort A; Gertow J; Mattsson J; Uhlin M
Article: PROSTATE. 2014;74(14):1391-1399

Novel method to characterize immune cells from human prostate tissue.

Norström MM; Rådestad E; Stikvoort A; Egevad L; Bergqvist M; Henningsohn L; Mattsson J; Levitsky V; Uhlin M
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2013;19(5):838-844

Chimerism patterns of long-term stable mixed chimeras posthematopoietic stem cell transplantation in patients with nonmalignant diseases: follow-up of long-term stable mixed chimerism patients.

Stikvoort A; Gertow J; Sundin M; Remberger M; Mattsson J; Uhlin M

Alla övriga publikationer

Conference publication: BONE MARROW TRANSPLANTATION. 2023;58(SUPP1):355

GAMMA DELTA T CELLS RECONSTITUTION IN LONG-TERM SURVIVORS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

Alagrafi F; Stikvoort A; Gaballa A; Arruda L; Poiret T; Uhlin M
Conference publication: BLOOD. 2022;140:8350

Comprehensive Exploration of NK Cell Education in ADCC Triggered By a Monoclonal Antibody or a Bispecific Killer Engager Molecule (BiKE)

Leijonhufvud C; Schlums H; Stikvoort A; Uhlin M; Bryceson YT; Carlsten M
Review: VIRUSES-BASEL. 2021;13(6):1031

Revisiting the Role of γδ T Cells in Anti-CMV Immune Response after Transplantation.

Gaballa A; Alagrafi F; Uhlin M; Stikvoort A
Meeting abstract: BLOOD. 2019;134:5536

Targeting CD38^high Acute Myeloid Leukaemia with "Affinity Optimized" Chimeric Antigen Receptor and Membrane Bound TRAIL Expressing Natural Killer Cells

Nolan E; Stikvoort A; Gurney M; Burduli N; Kirkham-McCarthy L; Daly J; Van de Donk NWCJ; Mutis T; Sarkar S; O'Dwyer ME
Meeting abstract: BLOOD. 2018;132:3199

CD38^low Natural Killer Cells Transiently Expressing CD16^F158V m-RNA Potentiates the Therapeutic Activity of Daratumumab Against Multiple Myeloma with Minimal Effector NK Cell Fratricide

Sarkar S; Chauhan S; Stikvoort A; Natoni A; Daly J; Henderson R; Mutis T; O'Dwyer ME
Meeting abstract: BLOOD. 2018;132:3261

CD38 Specific Chimeric Antigen Receptor KHYG-1 Natural Killer Cells: A Potential "Off the Shelf" Therapy for Multiple Myeloma

Stikvoort A; Sarkar S; Poels R; van de Donk NWCJ; Zweegman S; O'Dwyer ME; Mutis T
Published conference paper: BONE MARROW TRANSPLANTATION. 2018;53(1):69-77

Assessment of TREC, KREC and telomere length in long-term survivors after allogeneic HSCT: the role of GvHD and graft source and evidence for telomere homeostasis in young recipients.

Gaballa A; Norberg A; Stikvoort A; Mattsson J; Sundberg B; Uzunel M; Remberger M; Uhlin M
Review: STEM CELLS INTERNATIONAL. 2017;2017:5738371-17

Lymphocytes in Placental Tissues: Immune Regulation and Translational Possibilities for Immunotherapy.

Erkers T; Stikvoort A; Uhlin M
Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2017;86(4):265

Assessment of TREC, KREC and telomere length in long term survivors after allogeneic HSCT: the role of GVHD and graft source and evidence for telomere homeostasis in young recipients

Gaballa A; Norberg A; Stikvoort A; Mattsson J; Sundberg B; Uzunel M; Remberger M; Uhlin M
Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2017;86(4):264

Identifying cellular subsets diagnostic for severity chronic GVHD

Stikvoort A; Chen Y; Radestad E; Karlsson-Torlen J; Tadepally L; Bjorklund A; Mikes J; Achour A; Gertow J; Sundberg B; Remberger M; Sundin M; Mattsson J; Brodin P; Uhlin M
Review: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2016;17(10):1705

T Cell Receptor Excision Circle (TREC) Monitoring after Allogeneic Stem Cell Transplantation; a Predictive Marker for Complications and Clinical Outcome.

Gaballa A; Sundin M; Stikvoort A; Abumaree M; Uzunel M; Sairafi D; Uhlin M
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2016;22(3):S415

Identifying Cellular Subsets Diagnostic for Severity and Organ Specific Chronic GVHD

Stikvoort A; Rodestad E; Gertow J; Torlen J; Sundin M; Mattsson J; Uhlin M
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2016;22(3):S179-S180

Prophylaxis for Herpes Simplex Virus Reactivation in Patients after Allogeneic Hematopoietic Stem Cell Transplantation; Effects and Clinical Outcome

Uhlin M; Stikvoort A; Sundin M; Mattsson J; Remberger M
Conference publication: EUROPEAN JOURNAL OF IMMUNOLOGY. 2016;46:845

Placenta-derived decidual stromal cells alter IL-2R expression and signaling in alloantigen-activated T cells

Erkers T; Solders M; Verlang L; Bergstrom C; Stikvoort A; Rane L; Nava S; Ringden O; Kaipe H
Conference publication: EUROPEAN JOURNAL OF IMMUNOLOGY. 2016;46:844

Identifying cellular subsets diagnostic for severity and organ specificity chronic GVHD

Stikvoort A; Chen Y; Radestad E; Torlen J; Sundberg B; Sundin M; Mattsson J; Brodin P; Uhlin M
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2015;21(2):S170

Risk Factors and Clinical Outcome for Herpes Simplex Virus Reactivation in Patients after Allogeneic Hematopoietic Stem Cell Transplantation

Uhlin M; Stikvoort A; Sundin M; Mattsson J; Remberger M
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2015;21(2):S351

An Increasing Severity of Chronic GvHD Is Associated to an Activated and Cytotoxic T Cell Mediated Immune-Phenotype

Stikvoort A; Radestad E; Torlen J; Mattsson J; Uhlin M
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2015;21(2):S182-S183

Long-Term Stable Mixed Chimerism in Patients Undergoing HSCT for Non-Malignant Disorders

Stikvoort A; Mattsson J; Sundin M; Uhlin M
Conference publication: BONE MARROW TRANSPLANTATION. 2015;50:S407-S408

Risk factors and clinical outcome for Herpes Simplex Virus reactivation in patients after allogeneic hematopoietic stem cell transplantation

Uhlin M; Stikvoort A; Sundin M; Mattsson J; Remberger M
Conference publication: BONE MARROW TRANSPLANTATION. 2015;50:S236

Long-term stable mixed chimerism in patients undergoing HSCT for non-malignant disorders

Stikvoort A; Mattsson J; Sundin M; Uhlin M; Sundberg B; Uzunel M
Conference publication: HLA. 2014;84(1):32

AN INCREASING SEVERITY OF cGvHD IS ASSOCIATED TO A MORE ACTIVATED AND CYTOTOXIC T-CELL MEDIATED IMMUNE-PHENOTYPE

Stikvoort A; Radestad E; Gertow J; Sundin M; Mattsson J; Uhlin M
Conference publication: BONE MARROW TRANSPLANTATION. 2014;49:S536-S537

AN INCREASING SEVERITY OF CGVHD IS ASSOCIATED TO A MORE ACTIVATED AND CYTOTOXIC T-CELL MEDIATED IMMUNE-PHENOTYPE

Stikvoort A; Radestad E; Gertow J; Sundin M; Mattsson J; Uhlin M
Conference publication: BONE MARROW TRANSPLANTATION. 2013;48:S248

Chimerism patterns of long-term stable mixed chimeras post-HSCT in patients with non-malignant diseases

Stikvoort A; Gertow J; Sundin M; Remberger M; Mattsson J; Uhlin M
Visa fler

Anställningar

Biträdande Lektor, Medicin, Huddinge, Karolinska Institutet, 2024-2026
Biträdande Lektor, Klinisk vetenskap, intervention och teknik, Karolinska Institutet, 2022-2024

Examina och utbildning

Medicine Doktorsexamen, Institutionen för onkologi-patologi, Karolinska Institutet, 2017

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI